BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6349538)

  • 21. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
    Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of lentinan for advanced prostate carcinoma].
    Tari K; Satake I; Nakagomi K; Ozawa K; Oowada F; Higashi Y; Negishi T; Yamada T; Saito H; Yoshida K
    Hinyokika Kiyo; 1994 Feb; 40(2):119-23. PubMed ID: 8128920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
    Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
    Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
    Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticancer immunotherapy with perorally effective lentinan].
    Hamuro J
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1209-15. PubMed ID: 16121931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].
    Wada T; Nishide T; Hatayama K; Chang SW; Tatsuta M; Yasutomi M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2509-12. PubMed ID: 3113339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
    Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
    Shimizu K; Watanabe S; Watanabe S; Matsuda K; Suga T; Nakazawa S; Shiratori K
    Hepatogastroenterology; 2009; 56(89):240-4. PubMed ID: 19453066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
    Fujimoto K; Tomonaga M; Goto S
    Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer.
    Yoshino S; Watanabe S; Imano M; Suga T; Nakazawa S; Hazama S; Oka M
    Hepatogastroenterology; 2010; 57(97):172-7. PubMed ID: 20422897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
    Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
    Nishihira T; Akimoto M; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
    Kagawa R; Nakayama N; Yamaguchi T; Sakata S; Tada M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1989-94. PubMed ID: 12465402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
    Kitamura S; Ohtani T; Kurihara M; Kosaki G; Akazawa S; Sasaki T; Takahashi H; Nakano S; Tokunaga K
    Gan To Kagaku Ryoho; 1995 May; 22(6):765-75. PubMed ID: 7755384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
    Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
    Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.